Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound nose drops and its prepn.

A technique for nasal drops and compound recipes, applied in the preparation field of the nasal drops, can solve the problems of inability to cure completely, poor rhinitis treatment effect and the like

Inactive Publication Date: 2002-02-20
杨俊爱
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinically, the treatment effect on rhinitis is relatively poor. For example, the clinically used drugs such as Dibijing, ephedrine nasal drops, and Bitong ointment can only relieve symptoms, but cannot completely cure them.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0053] 1. The drug ratio of each component:

[0054] 80 milliliters of naphazoline hydrochloride nasal drops, wherein contain naphazoline hydrochloride 0.1%, can adopt the naphazoline hydrochloride nasal drops (the specification is 8ml: 0.1%) produced by Shijiazhuang Xinhua Pharmaceutical Factory;

[0055] 50 milliliters of lincomycin hydrochloride solution, which contains 15 grams of lincomycin hydrochloride, can adopt the lincomycin hydrochloride injection (the specification is 2ml: 0.6g) produced by North China Pharmaceutical Group Co., Ltd.;

[0056] 45 milliliters of prednisolone acetate solution, wherein contains prednisolone acetate 1125 milligrams, can adopt the prednisolone acetate injection (the specification is 5ml: 125mg) that Zhejiang Medicine Co., Ltd. Xianju Pharmaceutical Factory produces.

[0057] 2. Preparation method:

[0058] Said medicine is mixed according to the above-mentioned proportions, prepared and then packed into nasal drop bottles (each 8ml) for...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invented naristillae is composed of naphazoline hydrochloride nose drop 3-8 ml. contianing 0.1% naphazoline hydrochloride, lincomycin hydrochloride solution 2-6 ml. containing 0.6-1.8 gm licomycin hydrochloride, prednisolone aectate solution 1-5 ml. containing prednisolone acetate 25-125 mg. Advantages include: apparent therapeutic effect quick action, easy to use it, no recurrence etc.

Description

technical field [0001] The invention relates to a nasal drop for treating rhinitis. The invention also relates to a preparation method of the nasal drop. Background technique [0002] Rhinitis is a common acute and chronic inflammation of the nasal mucosa and submucosa, accompanied by varying degrees of dysfunction. Acute rhinitis is an acute inflammation of the nasal mucosa, which belongs to a respiratory disease and occurs mostly in spring and autumn. Chronic rhinitis is a chronic inflammation of the nasal mucosa and submucosa, accompanied by varying degrees of dysfunction. Chronic rhinitis usually includes several types such as simple rhinitis, hypertrophic rhinitis, sicca rhinitis, and atrophic rhinitis. Allergic rhinitis is also called allergic rhinitis. Sinusitis is acute and chronic inflammation of sinus cavity mucosa. Because sinus mucosa is connected with nasal mucosa, it is mostly caused by the spread of rhinitis. Clinically, the curative...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7034A61P11/02
Inventor 杨俊爱王俊国
Owner 杨俊爱
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com